07.11.2019
- French drugmaker Sanofi has paid $315 million to investors to settle claims it dragged its feet on advancing the development of multiple sclerosis drug Lemtrada, which it acquired...
22.10.2018
- French drugmaker Sanofi is planning to deepen the rare diseases footprint of its Genzyme franchise at Cambridge, Massachusetts, US, where according to reports the business could...
29.07.2015
- French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...
16.06.2014
- The world's biggest would-be drugs merger hit a wall last month but speculation about smart ways that Pfizer could yet seal a deal with AstraZeneca remains intense. Even as talks...
18.06.2013
- ViroPharma is attracting preliminary interest from several pharmaceutical companies about buying the orphan drugmaker, according to three people familiar with the matter. While...
19.03.2013
- Drug sales will shrink further in France this year as government austerity measures curb healthcare spending in Europe's second-biggest drugs market, a study said on Tuesday. The...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
18.12.2012
- European regulators recommended against approval of Sanofi and Isis Pharmaceutical's Kynamro drug for treatment of a rare genetic disorder that causes unusually high cholesterol...
